Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

Jeffrey Conn, P., Christopoulos, Arthur, Lindsley, Craig W.·2009·Nature Reviews Drug Discovery
DOI 10.1038/nrd2760

Cited by (1,000)

Items 701–800 of 1,000

  1. E-pharmacophore-based screening of mGluR5 negative allosteric modulators for central nervous system disorder
    Sitrarasu Vijaya Prabhu, Sanjeev Kumar Singh · 2018 · Computational Biology and Chemistry
  2. Influence of Cholesterol and Its Stereoisomers on Members of the Serotonin Receptor Family
    Victoria Oakes, Cármen Domene · 2019 · Journal of Molecular Biology
  3. Discovery of VU0467319: an M 1 Positive Allosteric Modulator Candidate That Advanced into Clinical Trials
    Michael S. Poslunsey, Michael R. Wood, Changho Han, Shaun R. Stauffer, Joseph D. Panarese, Bruce J. Melancon, Julie L. Engers, Jonathan W. Dickerson, Weimin Peng, Meredith J. Noetzel et al. · 2024 · ACS Chemical Neuroscience
  4. Genetic Findings in Obsessive–Compulsive Disorder Connect to Brain‐Derived Neurotropic Factor and Mammalian Target of Rapamycin Pathways: Implications for Drug Development
    Marco A. Grados, Hyung Mo Sung, Se-Jin Kim, Siddharth Srivastava · 2014 · Drug Development Research
  5. Neurobiological Insights from mGlu Receptor Allosteric Modulation
    Daniel E. O’Brien, Peter Jeffrey Conn · 2015 · The International Journal of Neuropsychopharmacology
  6. Discovery and SAR of a novel series of potent, CNS penetrant M4 PAMs based on a non-enolizable ketone core: Challenges in disposition
    Michael R. Wood, Meredith J. Noetzel, James Christopher Tarr, Alice L. Rodriguez, Atin Lamsal, Sichen Chang, Jarrett J. Foster, Emery W. Smith, Peter S. Chase, Peter Hodder et al. · 2016 · Bioorganic & Medicinal Chemistry Letters
  7. Label-free impedance-based whole cell assay to study GPCR pharmacology
    Maarten L. J. Doornbos, Laura H. Heitman · 2018 · Methods in cell biology
  8. Employing novel animal models in the design of clinically efficacious GPCR ligands
    Sophie J. Bradley, Sajjad Ali Riaz, Andrew B. Tobin · 2014 · Current Opinion in Cell Biology
  9. Optimization of an ether series of mGlu5 positive allosteric modulators: Molecular determinants of MPEP-site interaction crossover
    Jason T. Manka, Paige N. Vinson, Karen J. Gregory, Ya Zhou, Richard Dafydd Williams, Kiran K. Gogi, Emily Days, Satya Jadhav, Elizabeth J. Herman, Hilde Lavreysen et al. · 2012 · Bioorganic & Medicinal Chemistry Letters
  10. 6-Aryl-3-pyrrolidinylpyridines as mGlu5 receptor negative allosteric modulators
    Jesse M. Weiss, Hermogenes N. Jimenez, Guiying Li, Myriam April, Michelle A. Uberti, Maria D. Bacolod, Robb Brodbeck, Darı́o Doller · 2011 · Bioorganic & Medicinal Chemistry Letters
  11. Discovery and structure–activity relationship of 1,3-cyclohexyl amide derivatives as novel mGluR5 negative allosteric modulators
    Hao Zhou, Sidney W. Topiol, Michel Grenon, Hermogenes N. Jimenez, Michelle A. Uberti, Daniel G. Smith, Robbin M. Brodbeck, Gamini Chandrasena, Henrik Pedersen, Jens Christian Madsen et al. · 2013 · Bioorganic & Medicinal Chemistry Letters
  12. Using Ligand‐Based Virtual Screening to Allosterically Stabilize the Activated State of a GPCR
    Christina M. Taylor, Nicole B. Rockweiler, Cassie Liu, Loryn Rikimaru, Anna‐Karin Tunemalm, Oleg G. Kisselev, Garland R. Marshall · 2010 · Chemical Biology & Drug Design
  13. Further optimization of the M1 PAM VU0453595: Discovery of novel heterobicyclic core motifs with improved CNS penetration
    Joseph D. Panarese, Hykeyung P. Cho, Jeffrey J. Adams, Kellie D. Nance, Pedro M. García-Barrantes, Sichen Chang, Ryan D. Morrison, Anna Louise Blobaum, Colleen Marie Niswender, Shaun R. Stauffer et al. · 2016 · Bioorganic & Medicinal Chemistry Letters
  14. Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M1 Muscarinic Acetylcholine Receptors
    Emma T. van der Westhuizen, Arthur Spathis, Elham Khajehali, Manuela Jörg, Shailesh N. Mistry, Ben Capuano, Andrew B. Tobin, Patrick Michael Sexton, Peter J. Scammells, Céline Valant et al. · 2018 · Molecular Pharmacology
  15. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors
    Shome Sankar Bhunia, Anil Kumar Saxena · 2020 · Current Topics in Medicinal Chemistry
  16. Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A1 adenosine receptor
    Romeo Romagnoli, Pier Giovanni Baraldi, María Dora Carriòn, Olga Cruz‐López, Luisa Carlota Lopez-Cara, Giulia Saponaro, Delia Preti, Mojgan Aghazadeh Tabrizi, Stefania Baraldi, Allan R. Moorman et al. · 2013 · Bioorganic & Medicinal Chemistry
  17. A Hybrid Indoloquinolizidine Peptide as Allosteric Modulator of Dopamine D1 Receptors
    Aroa Soriano, Marc Vendrell, Sergio Gonzalez, Josefa Mallol, Fernando Alberício, Míriam Royo, Carmen Lluís, Enric I. Canela, Rafael Franco, Antoni Cortés et al. · 2009 · Journal of Pharmacology and Experimental Therapeutics
  18. Progress in GPCR structure determination
    Xiangli Qu, Dejian Wang, Beili Wu · 2019 · Elsevier eBooks
  19. Positive allosteric modulation of the cannabinoid CB1 receptor potentiates endocannabinoid signalling and changes ERK1/2 phosphorylation kinetics
    Hayley M. Green, Jamie J. Manning, Ian R. Greig, Ruth A. Ross, David B. Finlay, Michelle Glass · 2024 · British Journal of Pharmacology
  20. Bitopic Ligands Support the Presence of a Metastable Binding Site at the β2 Adrenergic Receptor
    Birgit I. Gaiser, Mia Danielsen, Xinyu Xu, Kira Røpke Jørgensen, Philipp Fronik, Emil Märcher-Rørsted, Tomasz M. Wróbel, Xiangyu Liu, Jesper Mosolff Mathiesen, Daniel Sejer Pedersen · 2024 · Journal of Medicinal Chemistry
  21. Allosteric Modulators of Potential Targets Related to Alzheimer's Disease: a Review
    Guilherme Martins Silva, Mariana Pegrucci Barcelos, João Gabriel Curtolo Poiani, Lorane Izabel da Silva Hage-Melim, Carlos Henrique Tomich de Paula da Silva · 2019 · ChemMedChem
  22. Allosteric targeting of the FFA2 receptor (GPR43) restores responsiveness of desensitized human neutrophils
    Robert Frei, Johannes Nordlohne, Ulrike Hüser, Seda Hild, Johannes Schmidt, Frank Eitner, Manuel Grundmann · 2020 · Journal of Leukocyte Biology
  23. Dynamical Correlations Reveal Allosteric Sites in G Protein-Coupled Receptors
    Pedro Renault, Jesús Giraldo · 2020 · International Journal of Molecular Sciences
  24. MptpA Kinetics Enhanced by Allosteric Control of an Active Conformation
    Federica Maschietto, Erik Zavala, Brandon Allen, J. Patrick Loria, Víctor S. Batista · 2022 · Journal of Molecular Biology
  25. Visualizing the endocytosis of phenylephrine in living cells by quantum dot-based tracking
    Jing Ma, Lina Wu, Zhun Hou, Yao Song, Lei Wang, Wei Jiang · 2014 · Biomaterials
  26. High-throughput Live Cell Imaging and Analysis for Temporal Reaction of G Protein-coupled Receptor Based on Split Luciferase Fragment Complementation
    Mitsuru Hattori, Takeaki Ozawa · 2015 · Analytical Sciences
  27. Detection and Quantification of Allosteric Modulation of Endogenous M4 Muscarinic Acetylcholine Receptor Using Impedance-Based Label-Free Technology in a Neuronal Cell Line
    Amy N. Y. Chen, Daniel T. Malone, Kavita Pabreja, Patrick Michael Sexton, Arthur Christopoulos, Meritxell Canals · 2014 · SLAS DISCOVERY
  28. Cell-Based Assays and Animal Models for GPCR Drug Screening
    Hideo Takakura, Mitsuru Hattori, Miho Tanaka, Takeaki Ozawa · 2015 · Methods in molecular biology
  29. Molecular Basis for Modulation of Metabotropic Glutamate Receptors and Their Drug Actions by Extracellular Ca2+
    Juan Zou, Jason Jiang, Jenny Jie Yang · 2017 · International Journal of Molecular Sciences
  30. 6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M1 mAChR: The Determinants of Allosteric Activity
    Manuela Jörg, Emma T. van der Westhuizen, Elham Khajehali, Wessel A. C. Burger, Jonathan Michael White, Kwok Ho Christopher Choy, Andrew B. Tobin, Patrick Michael Sexton, Céline Valant, Ben Capuano et al. · 2018 · ACS Chemical Neuroscience
  31. Exploring the Activation Mechanism of the mGlu5 Transmembrane Domain
    Isaías Lans, Óscar Díaz, James A. R. Dalton, Jesús Giraldo · 2020 · Frontiers in Molecular Biosciences
  32. Search for Structural Basis of Interactions of Biogenic Amines with Human TAAR1 and TAAR6 Receptors
    Anna V. Glyakina, Constantine D. Pavlov, Julia V. Sopova, Raul R. Gainetdinov, Е. И. Леонова, Oxana V. Galzitskaya · 2021 · International Journal of Molecular Sciences
  33. An intelligent, autocatalytic, DNAzyme biocircuit for amplified imaging of intracellular microRNAs
    Mei-Rong Cui, Dan Zhang, Qingfu Wang, Jie Chao · 2022 · Nanoscale
  34. Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think Tank
    Brian Dean, Hans‐Jürgen Möller, Torgny H. Svensson, Mark A. Geyer, Dan Rujescu, Elizabeth Scarr, Mark John Millan · 2013 · The International Journal of Neuropsychopharmacology
  35. Identification of an allosteric site on the E3 ligase adapter cereblon
    Dippon, Vanessa N., Rizvi, Zeba, Choudhry, Anthony E., Chung, Chun-wa, Alkuraya, Ibrahim F., Xu, Wenqing, Tao, Xavier B., Jurewicz, Anthony J., Schneck, Jessica L., Chen, Wenqian et al. · 2026 · Nature
  36. The function of GPCRs in different bone cells
    Yan Zhang, Naining Wang, Zihan Qiu, Jiahao Wang, Wen-Na An, Li-Dan Shi, Fei Chen, Dajin Zhang, Siyue Wang, Tie‐Lin Yang et al. · 2025 · International Journal of Biological Sciences
  37. ‘Partial’ competition of heterobivalent ligand binding may be mistaken for allosteric interactions: a comparison of different target interaction models
    Georges Vauquelin, David A. Hall, Steven J. Charlton · 2014 · British Journal of Pharmacology
  38. Octahydropyrrolo[3,4-c]pyrrole negative allosteric modulators of mGlu1
    Jason T. Manka, Alice L. Rodriguez, Ryan D. Morrison, Daryl F. Venable, Hyekyung P. Cho, Anna Louise Blobaum, John Scott Daniels, Colleen Marie Niswender, Peter Jeffrey Conn, Craig W. Lindsley et al. · 2013 · Bioorganic & Medicinal Chemistry Letters
  39. The neuroprotective effects of orthosteric agonists of group II and III mGluRs in primary neuronal cell cultures are dependent on developmental stage
    Danuta Jantas, A. Gręda, Sławomir Gołda, Michał Korostyński, Władysław Lasoń · 2016 · Neuropharmacology
  40. Elimination of a cholecystokinin receptor agonist ‘trigger’ in an effort to develop positive allosteric modulators without intrinsic agonist activity
    Aditya J. Desai, Brad R. Henke, Laurence J. Miller · 2015 · Bioorganic & Medicinal Chemistry Letters
  41. New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2). Identification and synthesis of N-propyl-5-substituted isoquinolones
    Andrés A. Trabanco, Guillaume Duvey, Jose Maria Cid, Gregor J. Macdonald, Philippe Cluzeau, Vanthea Nhem, Rocco Furnari, Nadia Behaj, Géraldine Poulain, Terry Finn et al. · 2010 · MedChemComm
  42. Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator
    Wenqi Hui, Qi Cheng, Tianyu Liu, Qin Ouyang · 2016 · Journal of Molecular Modeling
  43. Discovery and optimization of 3-(4-aryl/heteroarylsulfonyl)piperazin-1-yl)-6-(piperidin-1-yl)pyridazines as novel, CNS penetrant pan-muscarinic antagonists
    Aaron M. Bender, Rebecca L. Weiner, Vincent B. Luscombe, Sonia Ajmera, Hyekyung P. Cho, Sichen Chang, Xiaoyan Zhan, Alice L. Rodriguez, Colleen Marie Niswender, Darren W. Engers et al. · 2017 · Bioorganic & Medicinal Chemistry Letters
  44. Potentiation of Muscarinic M3 Receptor Activation through a New Allosteric Site with a Novel Positive Allosteric Modulator ASP8302
    Risa Okimoto, Katsutoshi Ino, Kenichiro Ishizu, Hajime Takamatsu, Kazuyuki Sakamoto, Hironori Yuyama, Hideyoshi Fuji, Akiyoshi Someya, Akiyoshi Ohtake, Takao Ishigami et al. · 2021 · Journal of Pharmacology and Experimental Therapeutics
  45. An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder
    Carolina L. Haass‐Koffler, Roberta Perciballi, Molly Magill, Antonella Loche, Roberto Cacciaglia, Lorenzo Leggio, Robert M. Swift · 2021 · Psychopharmacology
  46. Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity
    Lena Quambusch, Ina Landel, Laura Depta, Jörn Weisner, Niklas Uhlenbrock, Matthias Philipp Müller, Franziska Glanemann, Kristina Althoff, Jens Thomas Siveke, Daniel Rauh · 2019 · Angewandte Chemie
  47. NMDA Agonists for Autism Spectrum Disorders: Progress and Possibilities
    Stephen I. Deutsch, Jessica A. Burket, Andrew D. Benson, Maria R. Urbano · 2015 · Future Neurology
  48. N-Alkylpyrido[1′,2′:1,5]pyrazolo-[4,3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents
    Andrew S. Felts, Alice L. Rodriguez, Ryan D. Morrison, Daryl F. Venable, Anna Louise Blobaum, Frank W. Byers, John Scott Daniels, Colleen Marie Niswender, Carrie K. Jones, Peter Jeffrey Conn et al. · 2016 · Bioorganic & Medicinal Chemistry Letters
  49. Discovery of Selective Cannabinoid CB2 Receptor Agonists by High-Throughput Screening
    Lisa M. Ogawa, Neil T. Burford, Yu-Hsien Liao, Caitlin E. Scott, Ashley M. Hine, Craig J. Dowling, Jefferson A. Chin, Mike Power, Edward J. Hunnicutt, Victoria L. Emerick et al. · 2017 · SLAS DISCOVERY
  50. Discovery of Novel Muscarinic Receptor Modulators by Integrating a Natural Product Framework and a Bioactive Molecule
    Rajesh Varkhedkar, Shalini Dogra, Divya Tiwari, Yusuf Hussain, Prem Narayan Yadav, Ganesh D. Pandey · 2018 · ChemMedChem
  51. Fragment-Based Approaches for Allosteric Metabotropic Glutamate Receptor (mGluR) Modulators
    Zoltán Orgován, György G. Ferenczy, György Miklós Keserű · 2019 · Current Topics in Medicinal Chemistry
  52. Targeting the receptor-based interactome of the dopamine D1 receptor: looking for heteromer-selective drugs
    Verònica Casadó-Anguera, Antoni Cortés, Vicent Casadó, Estefanía Moreno · 2019 · Expert Opinion on Drug Discovery
  53. Reversible Control of Native GluN2B-Containing NMDA Receptors with Visible Light
    Geoffroy, Chloé, Berraud-Pache, Romain, Chéron, Nicolas, McCort-Tranchepain, Isabelle, Doria, Julia, Paoletti, Pierre, Mony, Laetitia · 2024 · ACS Chemical Neuroscience
  54. Biased signaling in drug discovery and precision medicine
    Renlei Ji, Ya‐Xiong Tao · 2025 · Pharmacology & Therapeutics
  55. Recent Advances in representative small-molecule DRD2 inhibitors: Synthetic Routes and clinical applications
    Yao Zhang, Jian-Gang Yu, Wen Wen · 2024 · European Journal of Medicinal Chemistry
  56. Impaired Sociability of the Balb/c Mouse, an Animal Model of Autism Spectrum Disorders, is Attenuated by NMDA Receptor Agonist Interventions: Clinical Implications
    Stephen I., Adamo Jessica, Maria R., Amy L., E. Erin · 2011 · InTech eBooks
  57. Insights into the structural biology of G-protein coupled receptors impacts drug design for central nervous system neurodegenerative processes.
    Farfán-García Eunice Dalet, Trujillo-Ferrara José Guadalupe, Castillo-Hernández María del Carmen, Guerra-Araiza Christian Humberto, Marvin Antonio Soriano-Ursua · 2013 · PubMed Central
  58. High affinity ligands and potent antagonists for the α1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives
    Giuseppe Romeo, Loredana Salerno, Valeria Pittalà, Maria Nunziata Modica, Maria Angela Siracusa, Luisa Materia, Michela Buccioni, Gabriella Marucci, Kenneth P. Minneman · 2014 · European Journal of Medicinal Chemistry
  59. QSAR study of mGlu5 inhibitors by genetic algorithm-multiple linear regressions
    Eslam Pourbasheer, Reza Aalizadeh, Mohammad Reza Ganjali, Parviz Norouzi, Alireza Banaei · 2013 · Medicinal Chemistry Research
  60. Optimization of Novel Aza-benzimidazolone mGluR2 PAMs with Respect to LLE and PK Properties and Mitigation of CYP TDI
    Joseph E. Pero, Michael A. Rossi, Michael J. Kelly, Hannah D. G. F. Lehman, Mark E. Layton, R. M. Garbaccio, Julie A. O’Brien, Brian C. Magliaro, Jason M. Uslaner, Sarah L. Huszar et al. · 2016 · ACS Medicinal Chemistry Letters
  61. Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis
    Mark E. Layton, Alexander J. Reif, Timothy J. Hartingh, Kevin J. Rodzinak, Vadim Dudkin, Cheng Wang, Kenneth L. Arrington, Michael J. Kelly, R. M. Garbaccio, Julie A. O’Brien et al. · 2016 · Bioorganic & Medicinal Chemistry Letters
  62. Assessing Allosteric Modulation of CB1 at the Receptor and Cellular Levels
    Caitlin E. Scott, Debra A. Kendall · 2017 · Methods in enzymology on CD-ROM/Methods in enzymology
  63. Development of Novel 4‐Arylpyridin‐2‐one and 6‐Arylpyrimidin‐4‐one Positive Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor
    Manuela Jörg, Elham Khajehali, Emma T. van der Westhuizen, Kwok Ho Christopher Choy, David M. Shackleford, Andrew B. Tobin, Patrick Michael Sexton, Céline Valant, Ben Capuano, Arthur Christopoulos et al. · 2020 · ChemMedChem
  64. Discovery of “Molecular Switches” within a Series of mGlu5 Allosteric Ligands Driven by a “Magic Methyl” Effect Affording Both PAMs and NAMs with In Vivo Activity, Derived from an M1 PAM Chemotype
    Lisa Barbaro, Alice L. Rodriguez, Ashlyn Blevins, Jonathan W. Dickerson, Natasha B. Billard, Olivier G. Boutaud, Jerri L. Rook, Colleen Marie Niswender, Peter Jeffrey Conn, Darren W. Engers et al. · 2021 · ACS Bio & Med Chem Au
  65. Co-operative binding assay for the characterization of mGlu4 allosteric modulators
    Pekka Poutiainen, Kun-Eek Kil, Zhaoda Zhang, Darshini Kuruppu, Bakhos A. Tannous, Anna‐Liisa Brownell · 2015 · Neuropharmacology
  66. Structural Features of Iperoxo–BQCA Muscarinic Acetylcholine Receptor Hybrid Ligands Determining Subtype Selectivity and Efficacy
    Matthew Charles Linford Wakeham, Briana J. Davie, David K. Chalmers, Arthur Christopoulos, Ben Capuano, Céline Valant, Peter J. Scammells · 2021 · ACS Chemical Neuroscience
  67. Synthesis of hexahydrocyclopenta[ij]isoquinolines as a new class of dopaminergic agents
    Javier Párraga, Abraham Galán, María‐Jesús Sanz, Nuria Cabedo, Diego Cortés · 2014 · European Journal of Medicinal Chemistry
  68. Synthesis, functional and binding profile of (R)-apomorphine based homobivalent ligands targeting the dopamine D2 receptor
    Jeremy Shonberg, J. Robert Lane, Peter J. Scammells, Ben Capuano · 2013 · MedChemComm
  69. GPCR Somatostatin Receptor Extracellular Loop 2 Is a Key Ectodomain for Making Subtype-Selective Antibodies With Agonist-Like Activities in the Pancreatic Neuroendocrine Tumor BON Cell Line
    Frank P. Leu, Minesh Nandi · 2010 · Pancreas
  70. The hydrophobic amino acids in putative helix 8 in carboxy-terminus of histamine H3 receptor are involved in receptor-G-protein coupling
    Atsuo Kuramasu, Jun Sukegawa, Takeya Sato, Eiko Sakurai, Takehiko Watanabe, Teruyuki Yanagisawa, Kazuhiko Yanai · 2011 · Cellular Signalling
  71. Effects of obesity induced by high-calorie diet and its treatment with exenatide on muscarinic acetylcholine receptors in rat hippocampus
    Marcelo Florencio Passos Silva, Patricia Lucio Alves, Rafaela Fadoni Alponti, Paulo Flávio Silveira, Fernando Maurício Francis Abdalla · 2019 · Biochemical Pharmacology
  72. Discovery of VU0431316: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety
    Brittney S. Bates, Alice L. Rodriguez, Andrew S. Felts, Ryan D. Morrison, Daryl F. Venable, Anna Louise Blobaum, Frank W. Byers, Kera P. Lawson, John Scott Daniels, Colleen Marie Niswender et al. · 2014 · Bioorganic & Medicinal Chemistry Letters
  73. Identification of small molecule NPR-B antagonists by high throughput screening — potential use in heart failure
    Trond Bach, Stine Bergholtz, Jon Riise, Eirik Qvigstad, Tor Skomedal, Jan‐Bjørn Osnes, Finn Olav Levy · 2013 · Naunyn-Schmiedeberg s Archives of Pharmacology
  74. Multivalent Approaches and Beyond: Novel Tools for the Investigation of Dopamine D 2 Receptor Pharmacology
    Anitha Kopinathan, Peter J. Scammells, J. Robert Lane, Ben Capuano · 2016 · Future Medicinal Chemistry
  75. Arrestin and G Protein Interactions with GPCRs: A Structural Perspective
    Carlos A.V. Barreto, Salete J. Baptista, Beatriz Bueschbell, Pedro R. Magalhães, António J. Preto, Agostinho Lemos, Nícia Rosário‐Ferreira, Anke C. Schiedel, Miguel Machuqueiro, Rita Melo et al. · 2022
  76. Further exploration of M1 allosteric agonists: Subtle structural changes abolish M1 allosteric agonism and result in pan-mAChR orthosteric antagonism
    Douglas J. Sheffler, Christian Sevel, Uyen Le, Kimberly M. Lovell, James Christopher Tarr, Sheridan J. S. Carrington, Hyekyung P. Cho, Gregory J. Digby, Colleen Marie Niswender, Peter Jeffrey Conn et al. · 2012 · Bioorganic & Medicinal Chemistry Letters
  77. 2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1 Receptor for Parkinson’s Disease
    Javier Garcı́a-Cárceles, Henar Vázquez‐Villa, Jose Manuel Brea, David Ladrón de Guevara‐Miranda, Giovanni Cincilla, Melchor Sánchez-Martínez, Anabel Sánchez-Merino, Sergio Algar, María Teresa de los Frailes, Richard S. Roberts et al. · 2022 · Journal of Medicinal Chemistry
  78. Investigation into biased signaling, glycosylation, and drug vulnerability of acute myeloid leukemia
    Tomasz Pienkowski, Aleksandra Golonko, Łukasz Bołkuń, Katarzyna Wawrzak-Pienkowska, Łukasz Szczerbiński, Adam Jacek Kretowski, Michał Ciborowski, W. Lewandowski, Waldemar Priebe, Renata Świsłocka · 2025 · Pharmacology & Therapeutics
  79. In Vitro Functional Characterization of GET73 as Possible Negative Allosteric Modulator of Metabotropic Glutamate Receptor 5
    Sarah Beggiato, Andrea Celeste Borelli, Maria Cristina Tomasini, M. Paola Castelli, Nicholas Pintori, Roberto Cacciaglia, Antonella Loche, Luca Ferraro · 2018 · Frontiers in Pharmacology
  80. Study of influence of the glutamatergic concentration of [18F]FPEB binding to metabotropic glutamate receptor subtype 5 with N-acetylcysteine challenge in rats and SRM/PET study in human healthy volunteers
    Anne-Claire Dupont, Sophie Sérrière, Laurent Barantin, Johnny Vercouillie, Clovis Tauber, Valérie Gissot, Sylvie Bodard, Gabrielle Chicheri, Sylvie Chalon, Frédérique Bonnet‐Brilhault et al. · 2021 · Translational Psychiatry
  81. Discovery of MK-8768, a Potent and Selective mGluR2 Negative Allosteric Modulator
    Michael T. Rudd, Peter J. Manley, Barbara Hanney, Zhaoyang Meng, Youheng Shu, Pablo de León, Jessica L. Frie, Yongxin Han, Jenny Miu-Chun Wai, Zhiqiang Yang et al. · 2023 · ACS Medicinal Chemistry Letters
  82. Positive allosteric modulators at GABAB receptors exert intrinsic actions and enhance the influence of baclofen on light-induced phase shifts of hamster circadian activity rhythms
    Robert L. Gannon, Mark John Millan · 2011 · Pharmacology Biochemistry and Behavior
  83. Metabolism-guided discovery of a potent and orally bioavailable urea-based calcimimetic for the treatment of secondary hyperparathyroidism
    Paul M. Wehn, Paul E. Harrington, Timothy J. Carlson, James Davis, Pierre Deprez, Christopher H. Fotsch, Mark P. Grillo, Jenny Ying-Lin Lu, Sean Morony, Kanaka Pattabiraman et al. · 2013 · Bioorganic & Medicinal Chemistry Letters
  84. The discovery and mechanism of sweet taste enhancers
    Xiaodong Li, Guy Servant, Catherine Tachdjian · 2011 · BioMolecular Concepts
  85. Heterotropic Cooperativity within and between Protomers of an Oligomeric M2Muscarinic Receptor
    Rabindra V. Shivnaraine, Xi‐Ping Huang, Margaret Seidenberg, John Ellis, James W. Wells · 2012 · Biochemistry
  86. Synthesis, structural properties, and pharmacological evaluation of 2-(acylamino)thiophene-3-carboxamides and analogues thereof
    Claudia Mugnaini, Valentina Pedani, Daniela Giunta, Barbara Sechi, Maurizio Solinas, Alberto Casti, M. Paola Castelli, Gianluca Giorgi, Federico Corelli · 2013 · RSC Advances
  87. Assay Development and High-Throughput Screening of Small Molecular c-Abl Kinase Activators
    Josh Cottom, Glenn A. Hofmann, Brett A. Siegfried, Jingsong Yang, Hong Zhang, Tracey Yi, Thau F. Ho, Chad J. Quinn, Da-Yuan Wang, Kyung Johanson et al. · 2010 · SLAS DISCOVERY
  88. Solution-Phase Parallel Synthesis and SAR of Homopiperazinyl Analogs as Positive Allosteric Modulators of mGlu 4
    Yiu‐Yin Cheung, Rocio Zamorano, Anna Louise Blobaum, C. David Weaver, Peter Jeffrey Conn, Craig W. Lindsley, Colleen Marie Niswender, Corey R. Hopkins · 2011 · ACS Combinatorial Science
  89. Generation and characterization of an antagonistic monoclonal antibody against an extracellular domain of mouse DP2 (CRTH2/GPR44) receptors for prostaglandin D2
    Nanae Nagata, Hiroko Iwanari, Hidetoshi Kumagai, Osamu Kusano‐Arai, Yuichi Ikeda, Kosuke Aritake, Takao Hamakubo, Yoshihiro Urade · 2017 · PLoS ONE
  90. Using machine learning tools for protein database biocuration assistance
    Caroline König, Ilmira Shaim, Alfredo Vellido, Enrique E. Romero, René Alquézar, Jesús Giraldo · 2018 · Scientific Reports
  91. Assays to Interrogate the Ability of Compounds to Inhibit the AF-2 or AF-1 Transactivation Domains of the Androgen Receptor
    Ashley T. Fancher, Yun Hua, Christopher J. Strock, Paul A. Johnston · 2019 · Assay and Drug Development Technologies
  92. Design, Synthesis, and Characterization of [ 18 F]mG2P026 as a High-Contrast PET Imaging Ligand for Metabotropic Glutamate Receptor 2
    Gengyang Yuan, Maëva Dhaynaut, Nicolas J. Guehl, Sepideh Afshar, Dalena Huynh, Sung‐Hyun Moon, Suhasini M. Iyengar, Manish Kumar Jain, Julie E. Pickett, Hye Jin Kang et al. · 2022 · Journal of Medicinal Chemistry
  93. Glucocerebrosidase Inhibitors: Future Drugs for the Treatment of Gaucher Disease?
    Ana Trapero, Amadeu Llebaria · 2014 · Future Medicinal Chemistry
  94. Computational screening of chemical constituents derived from berry fruits as allosteric caspace-3/-7 inhibitors
    Waseem Ahmad Ansari, Mohsin Ali Khan, S. M. Mahfooz Hasan, Zainab Siddiqui, Saheem Ahmad, Mohammad Faheem Khan, Mohammad Faheem Khan · 2024 · 3 Biotech
  95. Glutamate Metabotropic Receptors-Linked Postsynaptic Density Proteins: An Emergent Hub for Antipsychotics’ Regulation of Synaptic Plasticity and Metaplasticity
    Annarita Barone, Licia Vellucci, Anita Nasti, Benedetta Mazza, Federica Iannotta, Felice Iasevoli, Andrea de Bartolomeis · 2026 · Biomolecules
  96. The Design, Synthesis, and Evaluation of Novel 9-Arylxanthenedione-Based Allosteric Modulators for the δ-Opioid Receptor
    Owindeep Deo, Sadia Alvi, Vi Pham, Arthur Christopoulos, David M. Thal, Manuela Jörg, Ben Capuano, Céline Valant, Peter J. Scammells · 2022 · Journal of Medicinal Chemistry
  97. From Mouse to Man: N-Methyl-d-Aspartic Acid Receptor Activation as a Promising Pharmacotherapeutic Strategy for Autism Spectrum Disorders
    Stephen I. Deutsch, Jessica A. Burket · 2022 · Medical Clinics of North America
  98. The Impact of LY487379 or CDPPB on eNOS Expression in the Mouse Brain and the Effect of Joint Administration of Compounds with NO• Releasers on MK-801- or Scopolamine-Driven Cognitive Dysfunction in Mice
    Agata Płoska, Anna Siekierzycka, Paulina Cieślik, Lawrence W. Dobrucki, Leszek Kalinowski, Joanna Monika Wierońska · 2024 · Molecules
  99. Ciblage thérapeutique des récepteurs couplés aux protéines G
    Julien A. Sebag, Jacques Pantel · 2012 · médecine/sciences
  100. Characterization of a New Positive Allosteric Modulator of AMPA Receptors - PAM-43: Specific Binding of the Ligand and its Ability to Potentiate AMPAR Currents
    T. V. V’yunova, Л. А. Андреева, Konstantin V. Shevchenko, Vladimir V. Grigoriev, Vladimir A. Palyulin, Mstislav Igorevich Lavrov, Ekaterina V. Bondarenko, Elena E. Kalashnikova, Nikolai F. Myasoedov · 2020 · Current Molecular Pharmacology